DIGITAL IMAGING: IMPROVING DERMATOLOGY PATIENT CARE
FACULTY
Cheryl M. Burgess, MD
Assistant Clinical Professor of Dermatology
Georgetown University Medical Center
George Washington University Hospital
Medical Director
Center for Dermatology and Dermatologic Surgery
Washington, D.C.
Jeanine B. Downie, MD
Director, image Dermatology, P.C.
Assistant Attending
Mountainside and Overlook Hospitals
Montclair, N.J.
Case Study now available:
Digital Patient Care in Practice: An Interactive Case Study on Dermatological Imaging and Management
PURPOSE STATEMENT
Digital Imaging: Improving Dermatology Patient Care will focus on the role of digital imaging in the early detection, improved diagnosis, and management of a variety of dermatologic conditions and procedures, and will discuss strategies for integrating digital imaging solutions into dermatology practice.
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
- Recognize the potential applications of digital imaging to diagnose skin diseases and conditions with better precision and efficiency and keep accurate medical records.
- Define the role of digital imaging in a dermatology practice and how the technology integrates with existing practice systems.
- Develop office-based processes for employing digital imaging solutions to enhance communications with colleagues and patients to improve clinical outcomes visualization, patient adherence, and patient care.
TARGET AUDIENCE
Digital Imaging: Improving Dermatology Patient Care is intended for clinical and cosmetic dermatologists, plastic surgeons, and other healthcare professionals interested in the management of dermatology patients and the role of digital imaging.
ACCREDITATION INFORMATION
Expiration date: June 5, 2008
Physicians: Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Med-IQ designates this educational activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurses (CBRN): Med-IQ is a provider approved by the California Board of Registered Nursing, Provider Number CEP #14745, for 1.0 Contact Hours.
Pharmacists: 
1 contact hours (0.100 CEUs) of credit for pharmacists. This activity co-sponsored by Medical Education Collaborative, Inc. (MEC) and Med-IQ. MEC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE# 815-999-07-031-H01. The program is designed for all pharmacists.
Other Credit Information Nurse Practitioners: Med-IQ is accredited by ACCME to provide continuing medical education for physicians, and will provide nurse practitioners who successfully complete the activity with a Statement of Participation indicating that the activity was designated for 1 AMA PRA Category 1 CreditTM.
Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts AMA PRA Category 1 CreditTM for the PRA from organizations accredited by ACCME.
Disclosure Policy:
It is the policy of Med-IQ that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during presentation(s). Individuals who refuse to disclose will be disqualified from all aspects associated with this CME activity. Med-IQ has policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
Cheryl M. Burgess, MD
Consulting fees/advisory boards: Bioform, Allergan
Fees received for promotional/non-CME activities: sanofi-aventis U.S.
Contracted research: Medicis
Ownership interest (stocks/stock options – excluding mutual funds): Medicis, Allergan
Jeanine B. Downie, MD
Consulting fees/advisory boards: Allergan, Medicis, Johnson & Johnson
Fees received for promotional/non-CME activities: Novartis, Galderma
Contracted research: Johnson & Johnson, Allergan
Ownership interest (stocks/stock options – excluding mutual funds): Medicis, Allergan
Med-IQ Disclosure
Reshma Carter has disclosed that her spouse is an employee of Novartis Pharmaceuticals.
All other employees of Med-IQ have no financial relationships to disclose.
MEC Disclosure
The employees of Medical Education Collaborative have no financial relationships to disclose.
Acknowledgment of Commercial Support
This educational series is supported by an educational grant from sanofi-aventis U.S.